The global pharmaceutical packaging market was valued at $105.01 billion in 2023, and its growth is estimated to be $110.55 billion dollars in 2024 and $176.94 billion dollars by 2032 according to Fortune Business Insights. India being an emerging player in the pharmaceutical industry globally has witnessed exponential growth in requirements for different kinds of primary and secondary packaging. There has also been rapid growth in the number of manufacturers who are trying to cater to the growing demands in the market.
However, there are typical challenges faced by clients while availing critical packaging material from manufacturers. Despite quality production, products are broken or damaged owing to supply chain constraints and inefficiency. This is exactly why Kishore Group has created a private fleet of vehicles that delivers all products to clients with absolute safety and accuracy. The company is also equipped with the latest manufacturing technologies that provide faster productivity and goes in accordance with rapidly increasing of pharmaceutical manufacturing in the country.
Kishore Group has been in the business of manufacturing Pharmaceutical Packaging Products since 1959, currently in the 7th decade of service to the Pharmaceutical and Healthcare Industry. Over these years there have been tremendous changes and innovations in terms of manufacturing the products as well as end use of the product.
“Currently, our products are manufactured on High-Speed Automated Lines having nearly Zero Human Interference with the product to avoid contamination and prioritize consumer and patient safety”, mentioned Arjun Kishore Mehra, Director, Kishore Group.
Operational Excellence
Kishore Group has always believed in persistent growth through innovation and technology. Recently it has attained the USFDA DMF Certification for its products which opened opportunities for the company in the regulatory markets. Stringent norms, strict compliances and improvement in product quality were a few initial challenges it faced. The company’s highly experienced and dedicated workforce worked round the clock to overcome these challenges, which boosted all the products in the regulatory markets. India has evolved over the years and become a hub for pharmaceuticals drugs with supplies across the globe. “The increasing demand and the trust our customers, whom we consider our business partners, have in us has made Kishore Group grow to what we are today. Since we are a family run business, majority of our investments are own funded with negligible outside borrowings”, stated Arjun.
For a single moment the company does not forget the business it is into, that is manufacturing of Pharmaceutical Packaging Products for Life Saving Drugs and this mantra has also been embedded in each one employed under the company. Kishore Group has always focused on quality by attaining Zero Defects in its products across all locations. Frequent training programs, internal/external audits and a committed workforce has made this possible to adhere to Indian as well as International Standards and complying the products with the respective pharmaceutical norms (pharmacopeia) in force.
Kishore Group has always believed in persistent growth through innovation and technology. Recently it has attained the USFDA DMF Certification for its products, which opened opportunities for the company in the regulatory markets
Looking at the Future
The company is currently focusing on the European and South East Asian markets. Initially its plan would be having tie ups with the local distribution companies before venturing to direct sales to the end user. “The future looks bright for the company with great opportunities to expand not only production wise but introduction of new product range in the field of Primary as well as Secondary Pharmaceutical Packaging due to its growing demand. Our main areas of focus for growth would be R&D and New Product Development”, concluded Arjun.
We use cookies to ensure you get the best experience on our website. Read more...
